Andrew Findlay

Washington University

$1,900,439

Attributed

$1,900,439

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $556.2K · FY2019–25

$1M$750K$500K$250K$0

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$1,900,439 · 3

By mechanism

R01$1,047,312 · 1

K08$695,670 · 1

R03$157,457 · 1

Top collaborators

No co-investigators on record.

Most similar at Washington University

Same institution · by research overlap

Conrad C Weihl$15,584,686
Gerald W. Dorn$42,039,718
Heather L True-Krob$15,851,538
Jeffrey H Miner$20,654,870
William J Powers$13,261,590

Others in their field

Other Emerging Leaders on “In Vivo”

Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
Lynn Briscoe · Leidos Biomedical Research, Inc.$94,216,744
Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
John Damon Chodera · Sloan-Kettering Inst Can Research$43,427,103
Tony Moody · Duke University$34,777,314
Alan D. Palkowitz · Indiana University Indianapolis$18,925,366

Research focus

In VivoInheritedExperimental StudyKnock-InNeuromuscular DiseasesNeuromuscularProteinsTreatment StrategyMouse ModelLimb-Girdle Muscular DystrophiesMutationMutantMyoblastsMyopathyKnock-DownInduced Pluripotent Stem CellMuscular DystrophiesMuscleKnock-OutMuscle FibersInsightMolecular ChaperonesAdultInfrastructure